Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 4/20 | 0.46 |
| ▸ | CES1 | P23141 | 4/20 | 0.46 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.43 |
| ▸ | PPARG | P37231 | 6/20 | 0.43 |
| ▸ | PPARD | Q03181 | 6/20 | 0.43 |
| ▸ | PPARA | Q07869 | 6/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TLR2 | O60603 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | FABP4 | P15090 | 2/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28042801 | 0.92 | KMT2A (0.45) | KMT2AMAPTCES2CES1AKR1B1 | |
| SCHEMBL2990381 | 0.88 | NAAA (0.53) | KMT2AMAPTCES2CES1HAO1 | |
| SCHEMBL11625205 | 0.88 | NAAA (0.53) | KMT2AMAPTCES2CES1HAO1 | |
| SCHEMBL19508699 | 0.88 | NAAA (0.53) | KMT2AMAPTCES2CES1HAO1 | |
| SCHEMBL9571976 | 0.86 | MAPT (0.50) | KMT2AMAPTCES2CES1ALDH1A1 | |
| SCHEMBL9571985 | 0.86 | MAPT (0.42) | KMT2AMAPTCES2CES1ALDH1A1 | |
| SCHEMBL9571982 | 0.86 | MAPT (0.42) | KMT2AMAPTCES2CES1ALDH1A1 | |
| SCHEMBL9571981 | 0.86 | MAPT (0.50) | KMT2AMAPTCES2CES1ALDH1A1 | |
| SCHEMBL11928089 | 0.85 | GNAI3 (0.57) | KMT2AMAPTCES2CES1TDP1 | |
| SCHEMBL13485707 | 0.85 | CYP1A2 (0.45) | KMT2AMAPTCES2CES1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2575451-A1 | COMPOUNDS, METHODS, AND DEVICES FOR DETECTING AND/OR TREATING INSECT INFESTATION | Bayer Cropscience LP (US) | 2013-04-10 | — | — | EP | claimed |
| CN-103025157-A | Compounds, methods, and devices for detecting and/or treating insect infestation | BAYER CROPSCIENCE LP | 2013-04-03 | — | — | CN | claimed |
| WO-2011149901-A1 | COMPOUNDS, METHODS, AND DEVICES FOR DETECTING AND/OR TREATING INSECT INFESTATION | BAYER CROPSCIENCE LP (US) | 2011-12-01 | — | — | WO | claimed |
| EP-3283489-B1 | EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER | US HEALTH (US) | 2019-08-21 | — | — | EP | disclosed |
| US-10287297-B2 | Epoxyazulene derivatives useful for treating cancer and diabetes | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2019-05-14 | — | — | US | disclosed |
| US-20180127433-A1 | EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER AND DIABETES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN (US) | 2018-05-10 | — | — | US | disclosed |
| EP-3283489-A1 | EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER AND DIABETES | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services (US) | 2018-02-21 | — | — | EP | disclosed |
| WO-2016168281-A1 | EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER AND DIABETES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2016-10-20 | — | — | WO | disclosed |
| EP-2575443-A1 | IDENTIFICATION OF INSECT ATTRACTANT, ARRESTING, AND/OR AGGREGATION COMPOUNDS AND METHODS THEREOF | Bayer Cropscience LP (US) | 2013-04-10 | — | — | EP | disclosed |
| EP-2575451-A1 | COMPOUNDS, METHODS, AND DEVICES FOR DETECTING AND/OR TREATING INSECT INFESTATION | Bayer Cropscience LP (US) | 2013-04-10 | — | — | EP | disclosed |
| CN-103025157-A | Compounds, methods, and devices for detecting and/or treating insect infestation | BAYER CROPSCIENCE LP | 2013-04-03 | — | — | CN | disclosed |
| US-20110293553-A1 | IDENTIFICATION OF INSECT ATTRACTANT, ARRESTING, AND/OR AGGREGATION COMPOUNDS AND METHODS THEREOF | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2011-12-01 | — | — | US | disclosed |
| WO-2011149899-A1 | IDENTIFICATION OF INSECT ATTRACTANT, ARRESTING, AND/OR AGGREGATION COMPOUNDS AND METHODS THEREOF | BAYER CROPSCIENCE LP (US) | 2011-12-01 | — | — | WO | disclosed |
| WO-2011149901-A1 | COMPOUNDS, METHODS, AND DEVICES FOR DETECTING AND/OR TREATING INSECT INFESTATION | BAYER CROPSCIENCE LP (US) | 2011-12-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110293553-A1 | IDENTIFICATION OF INSECT ATTRACTANT, ARRESTING, AND/OR AGGREGATION COMPOUNDS AND METHODS THEREOF | L3MBTL3, ATG13, ARRB1 | KMT2A 3986/4885MAPT 867/4885CES2 1736/4885 |
| US-10287297-B2 | Epoxyazulene derivatives useful for treating cancer and diabetes | ESRRA, ESRRB, ESRRG | KMT2A 4077/4885MAPT 4877/4885CES2 1171/4885 |
| US-20180127433-A1 | EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER AND DIABETES | ESRRA, ESRRB, ESRRG | KMT2A 4077/4885MAPT 4877/4885CES2 1171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.